6/18
08:28 am
lgnd
Ligand Collaborator Merck Receives FDA Approval for CAPVAXIVE™ (Pneumococcal 21-valent Conjugate Vaccine) for Adults [Yahoo! Finance]
Low
Report
Ligand Collaborator Merck Receives FDA Approval for CAPVAXIVE™ (Pneumococcal 21-valent Conjugate Vaccine) for Adults [Yahoo! Finance]
6/18
08:00 am
lgnd
Ligand Collaborator Merck Receives FDA Approval for CAPVAXIVE™ (Pneumococcal 21-valent Conjugate Vaccine) for Adults
Low
Report
Ligand Collaborator Merck Receives FDA Approval for CAPVAXIVE™ (Pneumococcal 21-valent Conjugate Vaccine) for Adults
5/24
01:34 pm
lgnd
Agenus gains after updating early-stage cancer drug data [Seeking Alpha]
Low
Report
Agenus gains after updating early-stage cancer drug data [Seeking Alpha]
5/23
04:59 pm
lgnd
Ligand to Participate in Upcoming Investor Conferences
Low
Report
Ligand to Participate in Upcoming Investor Conferences
5/13
01:48 pm
lgnd
Ligand (LGND) Moves to Strong Buy: Rationale Behind the Upgrade [Yahoo! Finance]
Low
Report
Ligand (LGND) Moves to Strong Buy: Rationale Behind the Upgrade [Yahoo! Finance]
5/10
10:59 am
lgnd
Ligand (LGND) Is a Great Choice for 'Trend' Investors, Here's Why [Yahoo! Finance]
Low
Report
Ligand (LGND) Is a Great Choice for 'Trend' Investors, Here's Why [Yahoo! Finance]
5/9
11:49 am
lgnd
Are Medical Stocks Lagging Ligand Pharmaceuticals (LGND) This Year? [Yahoo! Finance]
Medium
Report
Are Medical Stocks Lagging Ligand Pharmaceuticals (LGND) This Year? [Yahoo! Finance]
5/9
07:53 am
lgnd
Ligand Pharmaceuticals First Quarter 2024 Earnings: EPS: US$4.86 (vs US$2.56 in 1Q 2023) [Yahoo! Finance]
High
Report
Ligand Pharmaceuticals First Quarter 2024 Earnings: EPS: US$4.86 (vs US$2.56 in 1Q 2023) [Yahoo! Finance]
5/8
02:33 pm
lgnd
Ligand (LGND) Beats Q1 Earnings, Misses Sales Estimates [Yahoo! Finance]
Low
Report
Ligand (LGND) Beats Q1 Earnings, Misses Sales Estimates [Yahoo! Finance]
5/8
08:08 am
lgnd
Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $144.00 price target on the stock.
Medium
Report
Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $144.00 price target on the stock.
5/7
07:13 pm
lgnd
Ligand Pharmaceuticals (LGND) Tops Q1 Earnings Estimates [Yahoo! Finance]
Medium
Report
Ligand Pharmaceuticals (LGND) Tops Q1 Earnings Estimates [Yahoo! Finance]
5/7
04:07 pm
lgnd
Ligand Reports First Quarter 2024 Financial Results [Yahoo! Finance]
Medium
Report
Ligand Reports First Quarter 2024 Financial Results [Yahoo! Finance]
5/7
04:00 pm
lgnd
Ligand Reports First Quarter 2024 Financial Results
Medium
Report
Ligand Reports First Quarter 2024 Financial Results
5/7
07:30 am
lgnd
Ligand and Agenus Enter Into $100 Million Royalty Financing Agreement
Medium
Report
Ligand and Agenus Enter Into $100 Million Royalty Financing Agreement
5/6
09:59 pm
lgnd
Don't Overlook These Top Medical Stocks as Q1 Earnings Approach [Yahoo! Finance]
Medium
Report
Don't Overlook These Top Medical Stocks as Q1 Earnings Approach [Yahoo! Finance]
4/29
10:31 pm
lgnd
Ligand: Buy This Pharma Royalty Aggregator To Generate Growth In Your Portfolio [Seeking Alpha]
Medium
Report
Ligand: Buy This Pharma Royalty Aggregator To Generate Growth In Your Portfolio [Seeking Alpha]
4/23
08:31 am
lgnd
Ligand to Report First Quarter 2024 Financial Results on May 7, 2024
Low
Report
Ligand to Report First Quarter 2024 Financial Results on May 7, 2024
4/12
10:08 am
lgnd
Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) had its "buy" rating re-affirmed by analysts at Benchmark Co.. They now have a $95.00 price target on the stock.
Low
Report
Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) had its "buy" rating re-affirmed by analysts at Benchmark Co.. They now have a $95.00 price target on the stock.
4/12
07:40 am
lgnd
CDK9 inhibitor Drug Pipeline Research Report 2024 [Yahoo! Finance]
Low
Report
CDK9 inhibitor Drug Pipeline Research Report 2024 [Yahoo! Finance]
4/9
06:57 am
lgnd
Can Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) Performance Keep Up Given Its Mixed Bag Of Fundamentals? [Yahoo! Finance]
Low
Report
Can Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) Performance Keep Up Given Its Mixed Bag Of Fundamentals? [Yahoo! Finance]
4/8
08:26 am
lgnd
Ligand Pharmaceuticals Announces New Topiramate Injection Data Presented at 9th London-Innsbruck Colloquium on Status Epilepticus and Acute Seizures Conference [Yahoo! Finance]
Low
Report
Ligand Pharmaceuticals Announces New Topiramate Injection Data Presented at 9th London-Innsbruck Colloquium on Status Epilepticus and Acute Seizures Conference [Yahoo! Finance]
4/8
08:15 am
lgnd
Ligand Pharmaceuticals Announces New Topiramate Injection Data Presented at 9th London-Innsbruck Colloquium on Status Epilepticus and Acute Seizures Conference
Low
Report
Ligand Pharmaceuticals Announces New Topiramate Injection Data Presented at 9th London-Innsbruck Colloquium on Status Epilepticus and Acute Seizures Conference
4/5
08:03 pm
lgnd
Ligand Pharmaceuticals (LGND) Stock Dips While Market Gains: Key Facts [Yahoo! Finance]
Low
Report
Ligand Pharmaceuticals (LGND) Stock Dips While Market Gains: Key Facts [Yahoo! Finance]
4/5
01:56 pm
lgnd
Ovid Therapeutics gains on bullish view at Wedbush [Seeking Alpha]
Low
Report
Ovid Therapeutics gains on bullish view at Wedbush [Seeking Alpha]
4/4
11:39 am
lgnd
Wall Street Analysts Think Ligand (LGND) Is a Good Investment: Is It? [Yahoo! Finance]
Low
Report
Wall Street Analysts Think Ligand (LGND) Is a Good Investment: Is It? [Yahoo! Finance]